The ABCs of Diagnosing Tardive Dyskinesia

Slides:

Advertisements

Similar presentations

Let’s Talk About Side Effects: Benefits and Risks of Mental Illness Medication ©2017 Neurocrine Biosciences, Inc. All Rights Reserved. CP-TD-US /17.

Advertisements

Answers to Your Questions About Tardive Dyskinesia

Hospital admissions per patient, by modality figure 5

Current Management and Future Options for Tardive Dyskinesia

Primary Care Challenges in Depression - To Treat or Refer?

Program Themes. Consulting on Common Concerns in PAH: How Would You Manage These Patients?

An Endocrinology Clinic in Dyslipidemia

Improving the Diagnosis and Treatment of Seizures in Long-term Care

MR Imaging in Children.

Essential Updates in Atopic Dermatitis:

5 Things NPs and PAs Need to Know About Tardive Dyskinesia

Management of Drug-Induced Movement Disorders: Focus on Tardive Dyskinesia.

The Clinical Enigma of Cardiogenic Shock

Exploring the Spectrum of Excessive Daytime Sleepiness

Challenges in the Diagnosis of MS: Physician and Nurse Perspectives

Introduction ESC Annual Meeting in Review: NOACs and NVAF: Real-World Data, Guidelines, and More.

The Patient Journey to Remission in MDD: A Collaborative Approach

Understanding the Many Faces of Pseudobulbar Affect

Differentiating Drug-Seeking Behavior From Poorly Controlled Pain

Neurogenic Orthostatic Hypotension: Expert Perspectives on Diagnosis and Treatment Strategies.

Individualizing Prophylaxis in Hemophilia

Case Challenges in Chronic Migraine

Before and After: Patient Cases in Onychomycosis

Introduction. Risk Communication With Patients: Your Guide to Resources and Recommendations.

Diagnosis and Management of Narcolepsy in Psychiatry:

Oral Anticoagulants in AFa,b A Brief History.

The Mood Disorder Spectrum

Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.

The Art and Science of Diagnosing Seizures

Time to Take Gout Seriously

Are We Closer to Personalized Medicine in MS?

Glaucoma: Detect, Diagnose, And Monitor The Silent Thief of Vision

Selected Causes of Cardiac Injury PEACE Trial High-Sensitivity Biomarker Substudy.

Approaches to the Patient With a Runny Nose

Forming Effective Individualized Treatment Plans for Patients With Low-Risk MDS.

Patients With T2D Presenting With Glycosuria: Examining the SGLT2 MOA

Clinical Recognition and Treatment of Levodopa-Induced Dyskinesia

Pseudobulbar Affect or Psychiatric Condition?

Insights Into the Spectrum of Tardive Dyskinesia

Impactful Data in TD That Can Guide Treatment Decisions

Introduction. Exploring Strategies for Recognition and Management of Lower Limb Spasticity in Children.

Hidden in Plain Sight: Disrupted Sleep in Patients With Pain

Taking the "Cryptogenic" Out of Cryptogenic Stroke

Introduction to AD. Practical Approaches to the Identification of Alzheimer Disease in Primary Care.

Parkinson Disease Psychosis

Preventing Clinical Events in PAH

Identifying High-Risk AF Patients

Tackling Schizophrenia With Your Patients

Cancer-Associated Thrombosis

Hepatitis C: After the Diagnosis

A systematic approach is needed in evaluating the mouth of elderly patients. All patients should receive a complete oral exam annually and more often if.

Insulin in Diabetes Management: Effective Patient Selection Is Key

Optimizing Joint Health in Hemophilia

The Psychiatrist's Role in Tardive Dyskinesia

Patient and Clinician Perspectives on Preventive Therapy for Migraine

Diagnosis, Evaluation, and Therapy for Severe Refractory Eosinophilic Asthma.

Communicating With Your Patients About Major Depressive Disorder

The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.

Patients With T2D Presenting With Glycosuria: Examining the SGLT2 MOA

Improving Adherence to Antiplatelet Therapy After an ACS Event

Program Goal. Program Goal Disclaimer Overview.

Taking the "Cryptogenic" Out of Cryptogenic Stroke

The Psychiatrist's Role in Tardive Dyskinesia

Binge Eating Disorder.

Importance of Early Diagnosis and Management in SMA

Tardive Dyskinesia 101.

Expert Insights in Diagnosis and Management of Common Drug-Induced Movement Disorders.

Management of Drug-Induced Movement Disorders: Focus on Tardive Dyskinesia.

Diagnosing HFpEF: What Every Cardiologist Needs to Know

Presentation transcript:

The ABCs of Diagnosing Tardive Dyskinesia

Defining TS

DRBAs Associated With TS

Defining TS (cont)

Common and Uncommon TS

Defining TS (cont)

TD Prevalence

Major Risk Factors for TS

TS: Signs

Differential Diagnosis of TD

Diagnosis of TD

The AIMS

Instructions for Performing AIMS Exam

Instructions for Performing AIMS Exam (cont)

Instructions for Performing AIMS Exam (cont)

Scoring the AIMS Procedure and Examples of Movements

Scoring the AIMS Global Judgments and Dental Status

The AIMS Additional Concerns

Monitoring Movement Disorders in Patients Taking Antipsychotic Agents

Prevention of TD

Conclusions

Abbreviations